EA202092224A1 - COMPOUNDS AND WAYS OF THEIR USE TO RELIEVE THE SYMPTOMS ASSOCIATED WITH MENOPAUSE - Google Patents

COMPOUNDS AND WAYS OF THEIR USE TO RELIEVE THE SYMPTOMS ASSOCIATED WITH MENOPAUSE

Info

Publication number
EA202092224A1
EA202092224A1 EA202092224A EA202092224A EA202092224A1 EA 202092224 A1 EA202092224 A1 EA 202092224A1 EA 202092224 A EA202092224 A EA 202092224A EA 202092224 A EA202092224 A EA 202092224A EA 202092224 A1 EA202092224 A1 EA 202092224A1
Authority
EA
Eurasian Patent Office
Prior art keywords
menopause
therapy
symptoms associated
compounds
relieve
Prior art date
Application number
EA202092224A
Other languages
Russian (ru)
Inventor
Мелани Тазо
Гладис Росин
Мод Йост
Мари Маве
Original Assignee
Эстетра Спрл
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Эстетра Спрл filed Critical Эстетра Спрл
Priority claimed from PCT/EP2019/060220 external-priority patent/WO2019202141A1/en
Publication of EA202092224A1 publication Critical patent/EA202092224A1/en

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

Настоящее изобретение относится к гормонозаместительной терапии, к связанным с ней соединениям и к связанным с ней упаковочным единицам для облегчения симптомов, связанных с менопаузой, при этом такая терапия основана на введении самке млекопитающего эстетрольного компонента в указанных суточных дозах, необязательно в комбинации с прогестогенным компонентом. Данная терапия обладает статистически значимой эффективностью в сочетании с благоприятным профилем побочных эффектов по сравнению с доступными в настоящее время методами для облегчения симптомов, связанных с менопаузой.The present invention relates to hormone replacement therapy, related compounds and related packaging units for alleviating symptoms associated with menopause, the therapy being based on the administration of the aesthetic component to the female mammal at the indicated daily doses, optionally in combination with a progestogen component. This therapy has statistically significant efficacy combined with a favorable side effect profile compared to currently available treatments for the relief of menopausal symptoms.

EA202092224A 2019-01-04 2019-04-19 COMPOUNDS AND WAYS OF THEIR USE TO RELIEVE THE SYMPTOMS ASSOCIATED WITH MENOPAUSE EA202092224A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP19150423 2019-01-04
PCT/EP2019/060220 WO2019202141A1 (en) 2018-04-19 2019-04-19 Compounds and their uses for alleviating menopause-associated symptoms

Publications (1)

Publication Number Publication Date
EA202092224A1 true EA202092224A1 (en) 2021-01-12

Family

ID=74222475

Family Applications (1)

Application Number Title Priority Date Filing Date
EA202092224A EA202092224A1 (en) 2019-01-04 2019-04-19 COMPOUNDS AND WAYS OF THEIR USE TO RELIEVE THE SYMPTOMS ASSOCIATED WITH MENOPAUSE

Country Status (1)

Country Link
EA (1) EA202092224A1 (en)

Similar Documents

Publication Publication Date Title
MD3781171T2 (en) Compounds and their uses for alleviating menopause-associated symptoms
MX2022013733A (en) Compounds and their uses for alleviating menopause-associated symptoms.
WO2018234568A3 (en) Hydroxynorketamine for the use in the treatment of depression
AR091706A1 (en) LAQUINIMOD FORMULATIONS WITHOUT ALKALINIZING AGENTS
MX2021005992A (en) Gaboxadol for reducing risk of suicide and rapid relief of depression.
MX2020011295A (en) Treatment of atopic dermatitis.
EA201690321A1 (en) APPLICATION OF ANTIBODY IMMUNOCONG CONTRACT TO MUC1 AND MAITANZINOID FOR THE TREATMENT OF SOLID TUMORS
UY35890A (en) USE OF LAQUINIMOD TO DELAY THE PROGRESSION OF HUNTINGTON'S DISEASE
EA202092224A1 (en) COMPOUNDS AND WAYS OF THEIR USE TO RELIEVE THE SYMPTOMS ASSOCIATED WITH MENOPAUSE
EA202092267A1 (en) COMPOUNDS AND WAYS OF THEIR USE TO RELIEVE THE SYMPTOMS ASSOCIATED WITH MENOPAUSE
MY180772A (en) Novel therapeutic mirtazapine combinations for use in pain disorders
MX2015007280A (en) Combination therapy for cancer.
MX2019014784A (en) Treatment for migraine.
MX2021011610A (en) Combinations of iadademstat for cancer therapy.
AR116592A1 (en) TREATMENT OF PRIMARY BILIARY CHOLANGITIS AND PRIMARY SCLEROSING CHOLANGITIS WITH BARICITINIB
AR114799A1 (en) COMPOUNDS AND THEIR USES TO RELIEVE SYMPTOMS RELATED TO MENOPAUSE
AR114798A1 (en) COMPOUNDS AND THEIR USES TO RELIEVE SYMPTOMS RELATED TO MENOPAUSE
PH12015500915A1 (en) Bremelanotide therapy for female sexual dysfunction
MX2022000426A (en) Telmisartan for the treatment of hypertension in dogs.
MX2022010593A (en) Topical diclofenac compositions and methods.
UA91815U (en) Method for treating psoriasis